| __timestamp | Arrowhead Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 675200000 |
| Thursday, January 1, 2015 | 34718089 | 771800000 |
| Friday, January 1, 2016 | 40998209 | 1205500000 |
| Sunday, January 1, 2017 | 32022880 | 1146500000 |
| Monday, January 1, 2018 | 19110051 | 1125800000 |
| Tuesday, January 1, 2019 | 26556257 | 1166100000 |
| Wednesday, January 1, 2020 | 52275890 | 1175500000 |
| Friday, January 1, 2021 | 80981000 | 1111400000 |
| Saturday, January 1, 2022 | 124431000 | 1210100000 |
| Sunday, January 1, 2023 | 90932000 | 1274600000 |
| Monday, January 1, 2024 | 98761000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, understanding spending patterns is crucial. Over the past decade, Perrigo Company plc and Arrowhead Pharmaceuticals, Inc. have showcased distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. Perrigo, a stalwart in the industry, consistently allocated substantial resources, with expenses peaking at approximately $1.27 billion in 2023, marking a 90% increase since 2014. In contrast, Arrowhead Pharmaceuticals, a rising star, demonstrated a more dynamic growth pattern. Their SG&A expenses surged by over 300%, from around $24 million in 2014 to nearly $99 million in 2024. This divergence highlights Perrigo's steady approach versus Arrowhead's aggressive expansion strategy. Notably, data for Perrigo in 2024 remains elusive, leaving room for speculation. As these companies navigate the complexities of the pharmaceutical world, their spending strategies offer valuable insights into their operational priorities and market positioning.
Comparing SG&A Expenses: Merck & Co., Inc. vs Perrigo Company plc Trends and Insights
SG&A Efficiency Analysis: Comparing Amgen Inc. and Perrigo Company plc
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Catalent, Inc. or Perrigo Company plc
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Perrigo Company plc
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.